Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Not Yet Recruiting

Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW)

NCT07269067

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

NCT06906380

Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, Anemia, +12 more
Locations: Novant Health Cancer Institute Charlotte, North Carolina, United States

Novant Health Cancer Institute Winston-Salem, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study

NCT07264010

Conditions: Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

NCT06303687

Conditions: Acute Pain, Burns, Hematologic Diseases, +18 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

NCT07233018

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML

NCT07026942

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

NCT07214064

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +12 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Not Yet Recruiting

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

NCT07201727

Conditions: AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

NCT06979076

Conditions: CLL (Chronic Lymphocytic Leukemia), Chronic Disease, Disease Attributes, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia

NCT06281847

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +10 more
Locations: Besançon Regional and University Hospital Besançon, France

Hospital Saint Louis Paris, France

Ludwig-Maximilians University of Munich Munich, Germany

University Hospital Ulm Ulm, Germany

View Trial Details

Leukemia

Leukemia trial results

Related conditions